Evaluation of local aggressive lung therapy versus systemic therapy in oligometastatic non-small cell lung cancer: a systematic review and meta-analysis.

J Thorac Dis · 2021 · PMC8575811 · PMID 34795938

Europe PMC DOI

hedged sentence

0.1600

closest p · 3.2× alpha

0.1600

boldest claim

The sentences

showed a trendP=0.16not close (p > 0.1)

As to adverse effects, LT group showed a trend of more adverse events compared to ST group (HR =1.84, 95% CI: 0.79–4.29), but with no statistical difference (P=0.16).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.